| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the * Department of Reproductive Genetics and
the
Department of Male Infertility,
Reproductive Biomedicine Research Center of Royan Institute, Tehran,
Iran.
| Correspondence to: Ramin Radpour, Department of Reproductive Genetics, Reproductive Biomedicine Research Center of Royan Institute, PO Box 19395-4644, Tehran, Iran (e-mail: rradpour{at}royaninstitute.org). |
| Received for publication April 6, 2007; accepted for publication July 30, 2007. |
| Abstract |
|---|
|
|
|---|
Key words: CBAVD, congenital bilateral absence of the vas deferens, IVS8-5T, male infertility
More than 1500 cystic fibrosis (CF)–causing CFTR mutations have been identified (Cystic Fibrosis Mutation Database, 2007), About 35% of Iranian males with CBAVD have a single detectable CFTR mutation or polymorphism, whereas about 40% have 2 mutations (common CFTR mutations or IVS8-5T polymorphism) (Radpour et al, 2007). About 88% of CBAVD patients in which a mutation is found on both CFTR genes carry 1 severe mutation on 1 CFTR gene and a mild mutation on the second CFTR gene, and about 12% carry mild mutations on both CFTR genes (Claustres et al, 2000). The most frequent CFTR mutation conferring a mild phenotype found in CBAVD patients is the 5T polymorphism (Chillon et al, 1995). 5T is one of the alleles found at the polymorphic Tn locus in intron 8 of the CFTR gene. The 5T polymorphism can be found in combination with either a TG11, TG12, or TG13 allele (11, 12, or 13 TG repeats, respectively).
Clinical symptoms of CBAVD are bilateral nonpalpable vas deferens, absence of the distal part of or the whole epididymis, and hypotrophy or absence of the seminal vesicles, leading to azoospermia with low semen plasma volume and acidic pH. Because the severity of CF is to some extent related to CFTR genotype, we tested this correlation between CBAVD and CUAVD with CFTR genotype. To study the correlation between genital phenotype and CF genotype in men lacking at least 1 vas deferens, we evaluated the role of different CFTR gene mutations in the morphologic genital phenotype of 119 infertile men with bilateral or unilateral absence of the vas deferens (112 CBAVD and 7 CUAVD patients). Also, epididymal and seminal vesicular abnormalities and testicular volume were compared among men with 2, 1, or no CFTR gene mutation, with or without the 5T allele.
| Materials and Methods |
|---|
|
|
|---|
|
|
|
CFTR Mutation Scanning![]()
As previously reported, DNA samples were analyzed, and all 27 exons of
CFTR were amplified by polymerase chain reaction (PCR) and studied by
denaturing gradient–gel electrophoresis or by single-strand conformation
analysis (Radpour et al,
2006a). Long-range PCR was performed to analyze the TGmTn site
(Radpour et al, 2007). The
results were confirmed by sequencing of PCR products. Sequencing results were
compared with the wild-type CFTR gene sequence published in the
Cystic Fibrosis Mutation Database
(http://www.genet.sickkids.on.ca/cftr/).
Statistical Analysis![]()
Six subgroups were analyzed to compare reproductive tract abnormalities: 2
CFTR gene mutations, 1 CFTR gene mutation and 5T
allele, 1 CFTR gene mutation, 2 5T alleles, 5T
alone, and no mutation. A Punnett square was constructed with the raw data and
compared with the predicted frequencies of each reported class with
5T and other mutations. Differences between percentages were tested
with the
2 test. Means (±SD) were compared with the
Student's t test (SPSS software version 14.0; SPSS Inc, Chicago,
Ill). All P values were 2-sided; P < .05 was considered
statistically significant.
| Results |
|---|
|
|
|---|
The analysis of the entire coding sequences of CFTR gene, allowed us to identify 19 different mutations in Iranian CBAVD patients (Radpour et al, 2007). These mutations have been described previously in Iranian patients with CBAVD (Radpour et al, 2006a,b). Of these, 5 cases were homozygous or compound heterozygous (+/+), 67 were positive for only 1 mutation (+/-), and 49 cases were negative for both mutations (-/-) (IVS8-5T was not involved). The result of our study reflects the high allelic heterogeneity of CFTR gene mutations, although 2 mutations, IVS8-5T and F508del, were found to be more common in Iranian CBAVD patients. Also a Punnett square was constructed with the raw data and compared with the predicted frequencies of each reported class with 5T and the other mutations. The frequencies of no mutation vs 5T, another mutation, or 5T with another mutation were predicted for CBAVD with a 62% mutation pickup rate, and 38% of cases were not detectable (Figure).
The 119 patients (112 CBAVD and 7 CUAVD) were classified into 6 subgroups
according to genotype to compare morphologic genital findings (Tables
4 and
5). Subgroups did not differ in
seminal vesicle status and symmetry of vesicular and epididymal abnormalities.
Two patients with 2 CFTR gene mutations lacked at least 1 seminal
vesicle, and 2 of them were dilated. Thirty-five patients had only 1
CFTR mutation and no 5T allele; 12 lacked at least 1 seminal
vesicle. From 11 patients with 2 5T alleles, seminal vesicles were
absent in 4 patients, 3 were hypotrophic, and 1 was dilated. Both seminal
vesicles were absent in 3 patients with the 5T allele only. Of the 22
men in whom no mutation was detected, seminal vesicles were absent or
hypotrophic in 16 cases (Table
4). Of the 7 men with unilateral absence of the vas deferens, 2
had the 5T allele and no other CFTR gene mutation
(Table 5). Epididymal
abnormalities in CBAVD patients were significantly more frequent in the group
without mutation than in the group with CFTR gene mutation, including
the 5T allele (82% compared with 45%, respectively; P = .01,
2 test). Also, testicular volume in CBAVD patients with no
CFTR mutations was significantly smaller than in men with
CFTR or IVS8-5T mutations
(Table 4) (15.3 ± 4.5 mL
compared with 11.2 ± 3.2 mL, respectively; P < .001,
Student's t test).
|
|
|
Taken together, seminal vesicle abnormalities did not differ between patients with or without CFTR gene mutations, but epididymal abnormalities were more frequent in CBAVD men without the mutation. Low testicular volume was observed in CBAVD men without the CFTR and IVS8-5T mutations.
| Discussion |
|---|
|
|
|---|
We found that patients with CBAVD and a CFTR mutation had the same seminal vesicle phenotype as patients without CFTR mutation. Also, the same result was obtained in CUAVD patients. Epididymal abnormalities were more frequent in men without mutation. These data are similar to previous findings in patients with CBAVD (Jarvi et al, 1998; Robert et al, 2002). Among men studied with scrotal ultrasonography, the frequency of intrascrotal abnormalities did not differ among subgroups of men with or without CFTR gene mutations. Daudin et al (2000) found no correlation between epididymal and seminal vesicle morphology and between CFTR gene mutations and the 5T allele in 32 patients. In contrast, our findings showed epididymal abnormalities were more frequent in CBAVD men without the mutation (P = .001). Because the number of CUAVD patients in our study was few, further studies are required for confirming genotype/phenotype analysis in Iranian CUAVD patients. Construction of Punnett squares of each reported class with 5T and other mutations showed that more significant differences exist between observed and predicted allele frequencies (Figure), and this finding supports the existence of another unlinked gene that is causing additional phenotypic abnormalities in addition to the existing abnormalities found within the other categories. In the majority of cases, CBAVD can be considered a genital form of CF, presenting without the other clinical features of CF. Generally, 20% have 2, 60% have 1, and 20% have no CFTR mutations. (Claustres, 2005). In our study, 19.64% of patients had no CFTR mutations (Table 4).
Analyses of the correlation between phenotype and genotype showed that the CFTR mutations could be grouped into 2 categories, mild or severe, with respect to pancreatic function (Kristidis et al, 1992). The severe mutations are associated with pancreatic insufficiency, whereas the mild mutations, leading to a higher residual CFTR activity, confer pancreatic sufficiency (Kristidis et al, 1992). A CF patient is likely to be pancreatic sufficient if he has 1 or 2 mild mutations. Several studies have shown that some genotypes are associated with a severe phenotype, whereas others have a milder clinical effect and evolution. In this study we could not find any reliable relation between CFTR gene mutations and CBAVD or CUAVD phenotype, and this is probably explained by defects in the genital ducts, from CFTR dysfunction, that occur after the splitting of the wolffian duct into its reproductive and ureteral parts at 7 weeks of gestation.
Given that CFTR mutations are detected in men with CBAVD and, with a lower frequency, in men with CUAVD, it appears that a normal amount of a functional CFTR protein is required to ensure proper development of the vas deferens. However, the lack of CFTR mutations detection in CBAVD with renal abnormalities also suggests that the mesonephric duct plays an important role in the development of the vas deferens. Therefore, it can hypothesize that the CFTR protein is required at some specific embryonic stage of the development of the vas deferens. The detection of CFTR mRNA in human fetuses suggests that CFTR acts as a chloride channel early in the development of the reproductive tissues (Tizzano et al, 1993). Also the epididymis and the vas deferens form a tortuous ductal system that is 7 m long but has a diameter less than 0.5 mm. The absence or dysfunction of CFTR would make these organs very vulnerable to luminal concentration defects, especially in the distal portion of the vas deferens, where CFTR expression level is low.
Testicular volume is small in about 5%–10% of patients with CBAVD (Jarvi et al, 1998; Daudin et al, 2000). Robert et al (2002) found a correlation between testicular volume and no CFTR mutation, for which testicular volume was smallest in these groups; this result was found in 47 patients. Our comprehensive study of 119 obstructive azoospermia confirmed the correlation between testicular volume and no CFTR or IVS8-5T mutations, for which testicular volume in CBAVD patients without detectable CFTR mutations were significantly low (P = .001). Therefore, we can hypothesize that a testicular factor (genetic or environmental) rather than CFTR gene mutations plays a role in determining the phenotype. Because of this contradiction, further studies and standardization of testicular volume are needed to confirm these observations.
Our results showed that patients with CBAVD and renal agenesis have the same reproductive tract abnormalities as those with CUAVD, and reproductive tract abnormalities were independent of the subtypes of CFTR genotype in patients with absence of the vas deferens and CFTR gene mutations. But only CBAVD men without CFTR gene mutations had more epididymal abnormalities. CBAVD men without CFTR gene mutations had smaller testicular volume. These different patterns could share some of the same pathogenic factors. Further studies with common diagnostic criteria are required to confirm the results.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet. 1993; 3: 151 –156.[CrossRef][Medline]
Claustres M. Molecular pathology of the CFTR locus in male infertility. Reprod Biomed Online. 2005; 10: 14 –41.[Medline]
Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, Girodon E, Cazeneuve C, Bienvenu T, Lalau G, Dumur V, Feldmann D, Bieth E, Blayau M, Clavel C, Creveaux I, Malinge MC, Monnier N, Malzac P, Mittre H, Chomel JC, Bonnefont JP, Iron A, Chery M, Georges MD. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat. 2000; 16: 143 –156.[CrossRef][Medline]
Cystic Fibrosis Mutation Database. Available at: http://www.genet.sickkids.on.ca/cftr/. Accessed March 2, 2007.
Daudin M, Bieth E, Bujan L, Massat G, Pontonnier F, Mieusset R. Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations and implications for genetic counseling. Fertil Steril. 2000;74: 1164 –1174.[CrossRef][Medline]
Dork T, Dworniczak B, Aulehla-Scholz C, Wieczorek D, Bohm I, Mayerova A, Seydewitz HH, Nieschlag E, Meschede D, Horst J, Pander HJ, Sperling H, Ratjen F, Passarge E, Schmidtke J, Stuhrmann M. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997;100: 365 –377.[CrossRef][Medline]
Egan M, Flotte T, Afione S, Solow R, Zeitlin PL, Carter BJ, Guggino WB. Defective regulation of outwardly rectifying Cl-channels by protein kinase A corrected by insertion of CFTR. Nature. 1992; 358: 581 –584.[CrossRef][Medline]
Jarvi K, McCallum S, Zielenski J, Durie P, Tullis E, Wilchanski M, Margolis M, Asch M, Ginzburg B, Martin S, Buckspan MB, Tsui LC. Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations. Fertil Steril. 1998; 70: 724 –728.[CrossRef][Medline]
Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet. 1992; 50: 1178 –1184.[Medline]
Radpour R, Sadighi Gilani MA, Gourabi H, Vosough Dizaj A. Molecular
study of (TG)m(T)n polymorphism in Iranian males with congenital bilateral
absence of the vas deferens. J Androl. 2007; 28: 541
–547.
Radpour R, Sadighi Gilani MA, Gourabi H, Vosough Dizaj A,
Mollamohamadi S. Molecular analysis of the IVS8-T splice variant
5T and M470V exon 10 missense polymorphism in Iranian males with
congenital bilateral absence of vas deferens. Mol Hum
Reprod. 2006a;12: 469
–473.
Radpour R, Sadighi Gilani MA, Gourabi H, Vosough Dizaj A, Rezaee M,
Mollamohamadi S. Two novel missense and one novel nonsense CFTR
mutations in Iranian males with congenital bilateral absence of the vas
deferens. Mol Hum Reprod. 2006b; 12: 717
–721.
Robert F, Bey-Omar F, Rollet J, Lapray JF, Morel Y. Relation between the anatomical genital phenotype and cystic fibrosis transmembrane conductance regulator gene mutations in the absence of the vas deferens. Fertil Steril. 2002; 77: 889 –896.[CrossRef][Medline]
Tizzano EF, Chitayat D, Buchwald M. Cell-specific localization of
CFTR mRNA shows developmentally regulated expression in human fetal tissues.
Hum Mol Genet. 1993; 2: 219
–224.
Welsh MJ, Smith AE. Cystic fibrosis. Sci Am. 1995;273: 52 –59.[Medline]
World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 1999 .
This article has been cited by other articles:
![]() |
K L Hahn, B Beres, M. J Rowton, M K Skinner, Y Chang, A Rawls, and J Wilson-Rawls A deficiency of lunatic fringe is associated with cystic dilation of the rete testis Reproduction, January 1, 2009; 137(1): 79 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Radpour, H. Gourabi, A. V. Dizaj, W. Holzgreve, and X. Y. Zhong Genetic Investigations of CFTR Mutations in Congenital Absence of Vas Deferens, Uterus, and Vagina as a Cause of Infertility J Androl, September 1, 2008; 29(5): 506 - 513. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |